Healio
Healio
More about

Chronic Glycemic Control

News
November 20, 2024
2 min read
Save

GLP-1RAs confer ‘metabolic benefit,’ lower odds for MASLD after liver transplantation

GLP-1RAs confer ‘metabolic benefit,’ lower odds for MASLD after liver transplantation

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated steatotic liver disease after liver transplantation, noted a presenter at The Liver Meeting.

CME
Video

DIABESITY DIALOGUES | Patient Perspectives for PCPs: Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders

DIABESITY DIALOGUES | Patient Perspectives for PCPs: Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders
1.00 AAPA
1.00 NCPD
60 MINS
$0 FEE
CME
Video

Harnessing the Power of the Community to Battle Obesity

Harnessing the Power of the Community to Battle Obesity
2.00 AAPA
2.00 CME
120 MINS
$0 FEE
CME
Video

Build Your Own Case Study | Obesity: Treating the Whole Patient

Build Your Own Case Study | Obesity: Treating the Whole Patient
1.00 CME
1.00 NCPD
60 MINS
$0 FEE
News
January 25, 2022
1 min read
Save

KDIGO bases new tools on 2020 clinical practice guideline for CKD

Kidney Disease: Improving Global Outcomes has launched two implementation tools based on a 2020 clinical practice guideline for the management of diabetes in chronic kidney disease, according to a press release from the foundation.

News
September 20, 2021
2 min read
Save

Icosabutate rapidly reduces biomarkers of liver injury in NASH

Icosabutate rapidly reduces biomarkers of liver injury in NASH

Two doses of icosabutate were well tolerated and safe in patients with nonalcoholic steatohepatitis.